Affinity Biologicals in Italy

CABRU distributes Affinity Biologicals in Italy, a Canadian manufacturer of antibodies, ELISA kits and deficient plasmas for haemostasis and thrombosis research. The CABRU catalogue lists 261 references, including 22 paired antibody sets and 44 deficient or control plasmas.

About Affinity Biologicals

Affinity Biologicals is based and manufactures in Ancaster, Ontario (Canada), and describes itself as a primary manufacturer of reagents for thrombosis and haemostasis research and diagnostics. Since 2018 it has been part of the Precision BioLogic group. Custom polyclonal antibody production, purification, conjugation, lyophilisation and reagent dispensing are all carried out in house: the whole chain from antiserum to finished kit stays under one roof.

What Affinity Biologicals makes

• Antibodies and conjugates against coagulation factors, available purified and conjugated to peroxidase, biotin or fluorescein. → Antibodies
• Matched antibody pairs for sandwich ELISA, with capture and detection antibodies already titrated together: 22 references in the catalogue.
• VisuLize ELISA kits complete with standards and controls for antigen measurement of individual factors. → ELISA kits
• Deficient and control plasmas, frozen or lyophilised, for more than thirty haemostasis analytes. → Plasmas

Application areas

The range covers coagulation and fibrinolysis research, the study of individual factors and their inhibitors, and the development and control of immunoenzymatic assays. Analytes addressed include factors II to XIII, fibrinogen, thrombin, protein C, von Willebrand factor and alpha-1-antitrypsin. → Haemostasis and coagulation

Affinity Biologicals references in the CABRU catalogue

Of the 261 references in the CABRU catalogue, 177 name an antibody, 44 are deficient or control plasmas and 102 refer to a specific coagulation factor. Around 183 references are classified under ELISA or ELISA/western blot applications. Plasmas are listed both frozen and lyophilised: the form should be stated when the request is placed.

Why the system matters more than the single reagent

In a haemostasis assay the risk is not the wrong reagent, it is the wrong combination: capture antibody from one manufacturer, detection from another, reference plasma from a third. Affinity supplies capture, detection, standards and deficient plasma from a single source, and CABRU frames the enquiry on that basis — analyte, format, plasma form — before quoting. CABRU distributes Affinity Biologicals in Italy on a non-exclusive basis. → Request information and a quote